STAGE IV PROSTATE CANCER
Clinical trials for STAGE IV PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo trial targets prostate Cancer's genetic weakness
Disease control OngoingThis study is testing whether combining two existing drugs works better than using them alone for men with advanced prostate cancer that has specific genetic flaws. It is for men whose cancer has spread and is no longer responding to standard hormone-blocking treatments. The tria…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test 'One-Two Punch' strategy to fight advanced prostate cancer
Disease control OngoingThis study is testing a two-step treatment plan for men with high-risk prostate cancer that has spread. First, patients receive strong hormone-blocking drugs. Then, they receive chemotherapy combined with hormone therapy. The goal is to see if this sequence can better control the…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Double attack on prostate cancer: testing a drug combo for tough cases
Disease control OngoingThis study is for men with advanced prostate cancer that has stopped responding to standard hormone therapy and has spread to the bones. It aims to see if adding a targeted radiation drug (Radium223) to a standard cancer-fighting pill (enzalutamide) works better than the pill alo…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists test 'Adaptive' strategy to outsmart advanced prostate cancer
Disease control OngoingThis early-stage study is testing a personalized, 'adaptive' treatment approach for men with advanced prostate cancer that has spread but still responds to hormone-blocking therapy. The goal is to see if adjusting the timing and dose of standard hormone therapy based on a patient…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Triple-Threat attack on prostate cancer shows promise
Disease control OngoingThis early-stage trial is testing whether combining three different treatments is safe for men with aggressive prostate cancer. The approach uses a hormone-blocking drug (enzalutamide), radiation therapy, and standard hormone injections to attack the cancer from multiple angles. …
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Feb 27, 2026 15:05 UTC
-
Scientists scan brains to see if cancer drugs cause 'Chemo Brain'
Knowledge-focused OngoingThis study aims to understand if two common prostate cancer drugs, abiraterone and enzalutamide, affect memory, concentration, and other thinking skills. Researchers will use brain scans and cognitive tests to compare 100 men with advanced prostate cancer who are taking these dru…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC